Investors added nearly 50% to the share price for Livongo Health (NSDQ:LVGO) today after it raised $355 million with its initial public offering after a last-minute upsizing. The Mountain View, Calif.-based company, which developed a digital health platform to manage chronic diseases, said earlier this week that it planned to float 10.7 million shares at $24 […]
livongohealth
Livongo boosts IPO to $268m midpoint
Livongo Health yesterday boosted the range on its pending initial public offering, saying the flotation would now fetch nearly $268 million at the midpoint. The Mountain View, Calif.-based company developed a digital health platform to manage chronic diseases, selecting diabetes as its first target. After a series of upsizing announcements, Livongo yesterday said it plans […]
Livongo Health files for $100m IPO
Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company’s initial focus on diabetes involves a smart, cellular-connected glucose meter, automatically-delivered testing materials, real-time coaching and full-time monitoring. The system personalizes messages based on each glucose […]
Livongo adds compatibility with Abbott’s FreeStyle Libre Pro
Livongo Health said today it will integrate continuous glucose data from Abbott‘s (NYSE:ABT) FreeStyle Libre Pro system into its Livongo for Diabetes system, touting it as the first such system to integrate data from Abbott’s FreeStyle Libre Pro. With the integration, users of the FreeStyle Libre Pro will be able to see a visual snapshot of […]
Livongo Health acquires weight-management, disease-prevention dev Retrofit
Livongo Health said yesterday it acquired weight-management and disease-prevention program developer Retrofit for an undisclosed amount. With the acquisition, Mountain View, Calif.-based Livongo Health said it will make Retrofit’s Diabetes Prevention program available as Livongo DPP, powered by Retrofit. Livongo said the acquisition acts as a compliment to its Livongo for Diabetes and Livongo for Hypertension […]
Livongo raises $105m for digital diabetes management platform
Livongo Health closed a $105 million round led by a group of investors including General Catalyst, Merck Global Health Innovation Fund and Echo Health Ventures. The Mountain View, Calif.-based company has developed Livongo for Diabetes – a collection of connected devices that enable people with diabetes to interact with a virtual care team. “We are particularly […]
Livongo buys diabetes management company Diabeto
Livongo Health said yesterday that it bought digital diabetes management company, Diabeto, for an undisclosed amount. Diabeto sells a connectivity technology called Birdie that plugs into more than 40 different glucose meters, connecting them to Diabeto’s mobile apps and to Livongo’s newly-released apps. “We’ve heard from the market that, in addition to a comprehensive solution […]
Livongo, Glytec ink deal for electronic diabetes management solution
Digital Health company Livongo Health said today that it is partnering with Glytec to develop a diabetes management solution that includes insulin titration. The companies plan to expand Glytec’s eGlycemic Management System to improve health outcomes in patients with diabetes. Glytec touted that its suite of FDA-cleared dosing algorithms for IV, subcutaneous and pediatric insulin […]
